While you might be going through the same day-in, day-out process to keep blood sugar levels in check, there’s a diabetes technology race afoot. Diabetes tech companies are trying to outdo each other with the latest pump, continuous glucose monitor (CGM), or app to help people with diabetes regulate blood glucose levels. Competition sparks innovation, and innovation means better treatment options for people with Type 1.
We’ve barely begun 2015, but early returns suggest it’s going to be a banner year for diabetes technology. Here are some breakthroughs we’ve noted in the first two months (click on links to the full articles):
Medtronic’s MiniMed 640G predicts blood sugar levels and adjusts insulin automatically to stave off lows.
Dexcom is the first CGM maker out of the gate to get FDA approval to market apps that share blood glucose readings.
Tandem is going big(ger) with its new pump.
There’s a lot of buzz surrounding an experimental CGM that’s as thin as a temporary tattoo.
A waterproof CGM would save a lot of heartache for Type 1 families.